Daniel Joseph Kerkman

Person

Lake Villa, IL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Certain substituted 1-aryl-3-piperazine-1′-yl propanones
- Patent number 7,173,132
- Issue date Feb 6, 2007
- Molecular Geriatrics Corporation
- John DeBernardis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purified antigen for Alzheimer's disease and methods of obtaining a...
- Patent number 6,864,062
- Issue date Mar 8, 2005
- Molecular Geriatrics Corporation
- Raymond P. Zinkowski
- G01 - MEASURING TESTING
Information Patent Grant
Methods for treating or preventing alzheimer's disease usin...
- Patent number 6,306,857
- Issue date Oct 23, 2001
- Molecular Geriatrics Corporation
- John Francis DeBernardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating or preventing alzheimer's disease usin...
- Patent number 6,228,878
- Issue date May 8, 2001
- Molecular Geriatrics Corporation
- John Francis DeBernardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Certain substituted 1-aryl-3-piperazin-1′-yl propanones
- Patent number 6,214,994
- Issue date Apr 10, 2001
- Molecular Geriatrics Corporation
- John Francis DeBernardis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Certain substituted 1-aryl-3-piperazin-1'-yl propanones
- Patent number 6,075,026
- Issue date Jun 13, 2000
- Molecular Geriatrics, Corp.
- John Francis DeBernardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating or preventing Alzheimer's Disease using substi...
- Patent number 5,968,936
- Issue date Oct 19, 1999
- Molecualr Geriatrics Corporation
- John Francis DeBernardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Certain substituted 1-aryl-3-morpholinopropanones to treat Alzheime...
- Patent number 5,705,501
- Issue date Jan 6, 1998
- Molecular Geriatrics Corporation
- John Francis DeBernardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 1-aryl-3-piperazin-1'-yl propanones
- Patent number 5,693,804
- Issue date Dec 2, 1997
- Molecular Geriatrics Corporation
- John Francis DeBernardis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Al...
- Patent number 5,658,909
- Issue date Aug 19, 1997
- Molecular Geriatrics Corporation
- John Francis DeBernardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Furyl and thienyl alkynyl-N-hydroxy urea derivatives
- Patent number 5,559,144
- Issue date Sep 24, 1996
- Abbott Laboratories
- Dee W. Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acetylene derivatives having lipoxygenase inhibitory activity
- Patent number 5,476,873
- Issue date Dec 19, 1995
- Abbott Laboratories
- Dee W. Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine u...
- Patent number 5,389,638
- Issue date Feb 14, 1995
- Abbott Laboratories
- John F. DeBernardis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Angiotensin II receptor antagonists
- Patent number 5,326,776
- Issue date Jul 5, 1994
- Abbott Laboratories
- Martin Winn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Angiotensin II receptor antagonists
- Patent number 5,250,548
- Issue date Oct 5, 1993
- Abbott Laboratories
- Martin Winn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,3-oxazolyl substituted biphenyl
- Patent number 5,210,206
- Issue date May 11, 1993
- Abbott Laboratories
- Howard E. Morton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Urea based lipoxygenase inhibiting compounds
- Patent number 5,185,363
- Issue date Feb 9, 1993
- Abbott Laboratories
- Dee W. Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the trea...
- Patent number 4,618,683
- Issue date Oct 21, 1986
- Abbott Laboratories
- John F. DeBernardis
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Method for Predicting Whether Subjects With Mild Cognitive Impairme...
- Publication number 20090022825
- Publication date Jan 22, 2009
- Applied NeuroSoloutions
- Daniel Kerkman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Purified Antigen for Alzheimer's Disease and Methods of Obtaining a...
- Publication number 20080181883
- Publication date Jul 31, 2008
- Applied NeuroSolutions formally known as Molecular Geriatrics Corporation
- Raymond P. Zinkowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Purified antigen for Alzheimer's disease and methods of obtaining a...
- Publication number 20050272094
- Publication date Dec 8, 2005
- Molecular Geriatrics Corporation
- Raymond P. Zinkowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for predicting whether subjects with mild cognitive impairme...
- Publication number 20040166536
- Publication date Aug 26, 2004
- Molecular Geriatrics Corporation
- Daniel Kerkman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Certain substituted 1-aryl-3-piperazine-1'-yl propanones
- Publication number 20030236403
- Publication date Dec 25, 2003
- Molecular Geriatrics Corporation
- John Francis DeBernardis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Purified antigen for Alzheimer's disease and methods of obtaining a...
- Publication number 20030113896
- Publication date Jun 19, 2003
- Raymond P. Zinkowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING...
- Publication number 20020002270
- Publication date Jan 3, 2002
- RAYMOND P. ZINKOWSKI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Certain substituted 1-aryl-3-piperazine-1'-yl propanones
- Publication number 20010025105
- Publication date Sep 27, 2001
- Molecular Geriatarics Corporation
- John DeBernardis
- C07 - ORGANIC CHEMISTRY

Daniel Joseph Kerkman

Person

Patents Grantslast 30 patents

Certain substituted 1-aryl-3-piperazine-1′-yl propanones

Purified antigen for Alzheimer's disease and methods of obtaining a...

Methods for treating or preventing alzheimer&#x00027;s disease usin...

Methods for treating or preventing alzheimer&#x00027;s disease usin...

Certain substituted 1-aryl-3-piperazin-1&#x02032;-yl propanones

Certain substituted 1-aryl-3-piperazin-1'-yl propanones

Methods for treating or preventing Alzheimer's Disease using substi...

Certain substituted 1-aryl-3-morpholinopropanones to treat Alzheime...

Substituted 1-aryl-3-piperazin-1'-yl propanones

Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Al...

Furyl and thienyl alkynyl-N-hydroxy urea derivatives

Acetylene derivatives having lipoxygenase inhibitory activity

Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine u...

Angiotensin II receptor antagonists

Angiotensin II receptor antagonists

1,3-oxazolyl substituted biphenyl

Urea based lipoxygenase inhibiting compounds

Tetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the trea...

Patents Applicationslast 30 patents

Method for Predicting Whether Subjects With Mild Cognitive Impairme...

Purified Antigen for Alzheimer's Disease and Methods of Obtaining a...

Purified antigen for Alzheimer's disease and methods of obtaining a...

Method for predicting whether subjects with mild cognitive impairme...

Certain substituted 1-aryl-3-piperazine-1'-yl propanones

Purified antigen for Alzheimer's disease and methods of obtaining a...

PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING...

Certain substituted 1-aryl-3-piperazine-1'-yl propanones

Methods for treating or preventing alzheimer's disease usin...

Methods for treating or preventing alzheimer's disease usin...

Certain substituted 1-aryl-3-piperazin-1′-yl propanones